With reference to the earlier letter dated July 18, 2016 regarding Financial Results for June 30, 2016, Span Diagnostics Ltd has now informed BSE that due to a clerical mistake, incorrect date of board meeting May 18, 2016 was mentioned at note no 1. to financial results instead July 18, 2016. Note No. 1 should be read as under:
The above financial results have been reviewed by the Audit Committee on July 18, 2016 and approved by the Board of Directors at their meeting held on July 18, 2016.
Span Diagnostics Ltd has informed BSE about :
- Standalone Financial Results for the period ended June 30, 2016
- Standalone Limited Review for the period ended June 30, 2016
Span Diagnostics Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Span Diagnostics Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on July 18, 2016, inter alia, to consider and approve the un-audited Financial Results of the Company for the quarter ended on June 30, 2015, subject to limited review by the statutory auditors along with other items of agenda.
Further, as per the Company’s Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for the aforesaid purpose with effect from July 11, 2016 for all the Directors / officers / Designated Employees of the Company. The Trading Window shall so remain closed until forty-eight (48) hours after the date of declaration / publication of the aforesaid un-audited financial results & shall re-open from the start of the business hours on July 21, 2016.
All the Directors/Officers/Designated Employees of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window.